The Bipolar Depression
Treatment Dynamic was conducted by StrategyOne, an applied research consulting firm, on behalf of the National Council for Community Behavioral Healthcare and AstraZeneca.
Symbyax is indicated in the United States for the acute treatment of bipolar depression
and treatment-resistant depression in adults.
Compared with placebo, four patients would need to be treated for bipolar depression
with Symbyax to achieve one greater response, or five patients would need to be treated with quetiapine.
published in the November 2003 issue of Archives of General Psychiatry, Symbyax helped to treat the symptoms of bipolar depression
more effectively and at a significantly faster rate than placebo.
Single-Dose Ketamine Followed by Daily d-Cycloserine in Treatment-Resistant Bipolar Depression
Data from the short-term, flexible-dose, placebo-controlled monotherapy bipolar depression
study are presented in Table 3.
agents, which should not be confused or used interchangeably with the term antidepressants, include effective medications for the treatment of bipolar depression
Richard Maddison, who suffers from bipolar depression
, said the drugs were for his own use and helped calm him down.
It is approved in 88 countries for the treatment of schizophrenia, in 79 countries for the treatment of bipolar mania, and in 11 countries including the US for the treatment of bipolar depression
THE world's first internet-based education treatment for patients with bipolar depression
is to be trialled by Cardiff University researchers.
Treatment of the symptoms of bipolar depression
remains an area of significant unmet medical need, as current therapies are ineffective and result in numerous side effects.
Clinicians often treat bipolar depression
with antidepressants as well, although they have worried that these substances may chemically jolt patients from depression into mania.